Allergan, Inc.
NYSE: AGN
$193.02
Closing Price on May 8, 2020
AGN Articles
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Thursday morning. The Blackstone Group LP (NYSE: BX) Started as Buy at Citigroup....
Published:
Last Updated:
If corporations have high credit ratings, there is an opportunity to borrow for rates that have not been seen in years (or ever). August saw key bond issuances at extremely low rates from Johnson...
Published:
Last Updated:
Allergan (NYSE: AGN) announced its second quarter earnings and a dividend of $.05 a share. The company can afford it. Allergan made $242 million in net income on $1.27 billion in sales. The specialty...
Published:
These are some of the more prominent analyst upgrades and downgrades seen this Friday morning from Wall Street research calls: Allergan Inc. (NYSE: AGN) Started as Outperform at Macquarie. ARM...
Published:
Last Updated:
These are the top ten analyst upgrades, downgrades, and initiations seen in Wall Street research calls this Monday morning: Advance Auto Parts Inc. (NYSE: AAP) Cut to Neutral at UBS. Allergan Inc....
Published:
Last Updated:
These are the top ten analyst upgrades and downgrades we have seen from Wall Street firms early this Monday morning: Allergan (AGN) Raised to Outperform at Baird. Burger King (BKC) Cut to Neutral at...
Published:
These are the top 10 analyst upgrades and downgrades we have seen from Wall Street firms early this Monday morning: Allergan (AGN) Raised to Buy at Citigroup. BJ Services (BJS) Cut to Underperform at...
Published:
Palomar Medical Technologies Inc. (NASDAQ: PMTI) is seeing shares surge to new heights not seen in 18-months. The company is the first to receive FDA approval for over-the-counter clearance for a...
Published:
Last Updated:
These are the top pre-market analyst upgrades and positive research calls we have seen from Wall Street this Tuesday morning: Allergan (AGN) Raised to Overweight at Thomas Weisel. China Unicom (CHU)...
Published:
If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover target. There is roughly $150 billion in new equity investor capital that can be put to work...
Published:
Last Updated:
These are the top analyst upgrades and positive research calls we have seen from Wall Street this Friday morning with about two hours until the market opens: Alcatel-Lucent (ALU) Raised to Outperform...
Published:
Last Updated:
These are the top pre-market analyst upgrades and positive research calls from Wall Street we have seen this Wednesday morning with more than two hours until the market opens: Allergan (AGN) Started...
Published:
Last Updated:
These are some of the top early bird upgrades and downgrades we have seen from Wall Street analysts this Monday morning: Agilent (NYSE: A) Raised to Outperform at Baird. Gentex (NASDAQ: GNTX) Raised...
Published:
Last Updated:
Jim Cramer came on CNBC’s MAD MONEY this week with several ideas for shotgun marriage merger proposals he wanted to throw out there where he was calling for more mergers from the cash rich...
Published:
Last Updated:
On tonight’s MAD MONEY on CNBC, Jim Cramer called for companies with high cash balances to make acquisitions while competitors are dirt cheap and vulnerable. Yesterday, Cramer called for Pfizer...
Published:
Last Updated: